Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment.

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The Transform trial, a collaborative effort funded by Prostate Cancer UK and the ...

Funeral services have been announced for Corpus Christi icon Ronnie “Pointy Boots” Mathis, according to longtime friend and ...

Farmers in Wales are being encouraged to get tested for prostate cancer, one of the most common for men, as part of a wider ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine ...

The Transform trial could produce results and lead to lifesaving changes in as little as two years.

New service offers rapid, consultant-led prostate scans to support early detection and a proactive approach to men’s health ...

Free prostate cancer screenings are being offered to men in the area as part of a health initiative. The Mohawk Valley Health ...

A funding standoff in Washington is disrupting airport security operations as unpaid TSA workers call out, triggering long lines during peak spring-break travel. President Donald Trump says he may ...

After Amanda Peet reflected on her breast cancer diagnosis in a candid essay, her friend Sarah Paulson shared a message of support.

The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.